This test records spots where sampled cells release a chosen substance. A spot count describes secretion under the test conditions; other assays address recognition or killing.
The original enzyme-linked immunospot method counted antibody-secreting cells; cytokine versions are used to examine stimulated immune-cell responses. Cancer Vaccine Consortium proficiency panels showed that sample handling, protocol choices and plate reading affected results. A result needs the measured molecule, stimulation, cell input, background and reporting rule. A positive secretion response alone does not show that the sampled cells recognize or kill an unmodified tumor.
Shares Intracellular cytokine staining, Immune-cell cytotoxicity assays, Immune measurements and product evidence.
Shares Immunogenicity and clinical efficacy, Immune measurements and product evidence.
Shares Immune-cell cytotoxicity assays, Immune measurements and product evidence.
Shares Immunogenicity and clinical efficacy, Immune-cell cytotoxicity assays, Immune measurements and product evidence.
Shares Peripheral blood mononuclear cell specimens, Immune measurements and product evidence.
Shares Intracellular cytokine staining, Peripheral blood mononuclear cell specimens, Immune-cell cytotoxicity assays.
Shares Peripheral blood mononuclear cell specimens, Immune measurements and product evidence.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/